Sangamo BioSciences (SGMO) Potential Fair Value Goes to $32/Share on BMRN CRL - Truist Securities

August 19, 2020 1:02 PM

Truist Securities analyst Nicole Germino reiterated a Buy rating and $22.00 price target on Sangamo BioSciences (NASDAQ: SGMO) after BMRN ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found